Congratulations to Kyverna Therapeutics Peter Maag Ryan Jones
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors Bain Capital Life Sciences and GordonMD® Global Investments LP join existing investors “I have supported anti-CD19 CAR T-cell therapy for cancer since the early clinical trials. It is exciting to see Kyverna break into new frontiers by advancing cell therapies for autoimmune diseases. I am looking forward to future developments from Kyverna,” said Craig Gordon, M.D., founder, chief executive officer, and chief investment officer of Gordon MD® Global Investments LP. #cellandgenetherapy Peter Maag Ryan Jones Kyverna Therapeutics GordonMD® Global Investments LP https://lnkd.in/g2bn-sAk